Medical device company
Appears in 1 story · Last updated Sep 20, 2026
As of September 2026: Developing Rhyvive, an investigational neuromodulation wearable
Roughly one in four patients who get atrial fibrillation ablation sees the arrhythmia return within a year. StimCardio Medical tested a wrist-worn device designed to change that, and the pilot results show it cut recurrent arrhythmia events by 57%.
Updated Sep 20
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
